This JAMA Clinical Guidelines Synopsis summarizes the 2024 Society of Critical Care Medicine guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia.
{"title":"Corticosteroids for Sepsis, Acute Respiratory Distress Syndrome, or Community-Acquired Pneumonia","authors":"Peggy B. Leung, Andrew M. Davis, Joshua Davis","doi":"10.1001/jama.2024.24537","DOIUrl":"https://doi.org/10.1001/jama.2024.24537","url":null,"abstract":"This JAMA Clinical Guidelines Synopsis summarizes the 2024 Society of Critical Care Medicine guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142936194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Noah M. Feder, Ryan O’Dea, Margaret Zupa, Jing Luo
This study examines trends in prescribing and reimbursement for glucagon products in Medicaid before and after the introduction of these newer products.
本研究考察了在引入这些新产品之前和之后，医疗补助中胰高血糖素产品的处方和报销趋势。
{"title":"Prescriptions and Reimbursement of Glucagon Products for Severe Hypoglycemia in Medicaid","authors":"Noah M. Feder, Ryan O’Dea, Margaret Zupa, Jing Luo","doi":"10.1001/jama.2024.25974","DOIUrl":"https://doi.org/10.1001/jama.2024.25974","url":null,"abstract":"This study examines trends in prescribing and reimbursement for glucagon products in Medicaid before and after the introduction of these newer products.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142936333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This Viewpoint focuses on the Manufacturer Discount Program, identifying 4 key themes of interest to policymakers that may be affected by its Part D redesign.
本观点关注制造商折扣计划，确定决策者感兴趣的4个关键主题，这些主题可能会受到D部分重新设计的影响。
{"title":"Assessing the Effect of the Medicare Part D Redesign","authors":"Rachel E. Sachs, Richard G. Frank","doi":"10.1001/jama.2024.25827","DOIUrl":"https://doi.org/10.1001/jama.2024.25827","url":null,"abstract":"This Viewpoint focuses on the Manufacturer Discount Program, identifying 4 key themes of interest to policymakers that may be affected by its Part D redesign.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142936302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Janine Austin Clayton, Diana W. Bianchi, Richard Hodes, Tara A. Schwetz, Monica Bertagnolli
ImportanceThis article highlights key National Institutes of Health (NIH) programs, policies, and scientific advances that have informed and improved the health of women and describe the promise and potential of harnessing cutting-edge science and integrative approaches to advance women’s health research. Policy updates combined with recent scientific and programmatic initiatives are intended to expand understanding of women’s health, deliver diagnostics, and develop preventive approaches and novel therapies to meet critical health needs of contemporary women.ObservationsTo benefit all people through the work funded and conducted by the NIH biomedical research enterprise, NIH has implemented policies that broadly expanded the knowledge of human health and disease from the laboratory to the clinic. Historically, women’s health research initially focused on reproductive health and female-specific conditions. It has since expanded to encompass all aspects of the health of women. As new knowledge is generated, novel insights are uncovered about how diseases and conditions affect women uniquely, differently, or disproportionately and how sex and gender, as biological and social factors, respectively, influence health and disease at multiple levels. Although cutting-edge research has generated scientific advances leading to lifesaving vaccines, diagnostics, and treatments for women, many still do not have access to them. Thus, the White House announced an initiative that catalyzes innovative, integrative women’s health research and propels translation from basic science to practical benefits, improving outcomes for all women across the lifespan.Conclusions and RelevanceNIH’s policies, programs, and research funding fill gaps in knowledge about the health of women. Their synergistic results generate evidence for data-driven decision-making and targeted interventions that will improve the health not just of women, but of all people.
{"title":"Recent Developments in Women’s Health Research at the US National Institutes of Health","authors":"Janine Austin Clayton, Diana W. Bianchi, Richard Hodes, Tara A. Schwetz, Monica Bertagnolli","doi":"10.1001/jama.2024.25878","DOIUrl":"https://doi.org/10.1001/jama.2024.25878","url":null,"abstract":"ImportanceThis article highlights key National Institutes of Health (NIH) programs, policies, and scientific advances that have informed and improved the health of women and describe the promise and potential of harnessing cutting-edge science and integrative approaches to advance women’s health research. Policy updates combined with recent scientific and programmatic initiatives are intended to expand understanding of women’s health, deliver diagnostics, and develop preventive approaches and novel therapies to meet critical health needs of contemporary women.ObservationsTo benefit all people through the work funded and conducted by the NIH biomedical research enterprise, NIH has implemented policies that broadly expanded the knowledge of human health and disease from the laboratory to the clinic. Historically, women’s health research initially focused on reproductive health and female-specific conditions. It has since expanded to encompass all aspects of the health of women. As new knowledge is generated, novel insights are uncovered about how diseases and conditions affect women uniquely, differently, or disproportionately and how sex and gender, as biological and social factors, respectively, influence health and disease at multiple levels. Although cutting-edge research has generated scientific advances leading to lifesaving vaccines, diagnostics, and treatments for women, many still do not have access to them. Thus, the White House announced an initiative that catalyzes innovative, integrative women’s health research and propels translation from basic science to practical benefits, improving outcomes for all women across the lifespan.Conclusions and RelevanceNIH’s policies, programs, and research funding fill gaps in knowledge about the health of women. Their synergistic results generate evidence for data-driven decision-making and targeted interventions that will improve the health not just of women, but of all people.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142929230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Christopher S. Evans, Robert W. Turer, John J. Hanna, Emilie Pendley, Richard J. Medford
This retrospective cohort study examines the incidence of return emergency department visits among patients who left without being seen at a prior index visit.
本回顾性队列研究调查了在先前的索引访问中未被看到的患者中返回急诊科的发生率。
{"title":"Emergency Department Return Visits After Having Left Without Being Seen","authors":"Christopher S. Evans, Robert W. Turer, John J. Hanna, Emilie Pendley, Richard J. Medford","doi":"10.1001/jama.2024.26825","DOIUrl":"https://doi.org/10.1001/jama.2024.26825","url":null,"abstract":"This retrospective cohort study examines the incidence of return emergency department visits among patients who left without being seen at a prior index visit.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142929231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This Medical News article is an interview with Dana P. Edelson, MD, MS, an expert in cardiac resuscitation at the University of Chicago and cofounder and chief medical officer of AgileMD, the company that makes the AI-driven early warning score software eCART.
这篇医学新闻文章是对Dana P. Edelson的采访，Dana P. Edelson是芝加哥大学的心脏复苏专家，也是AgileMD的联合创始人兼首席医疗官，该公司开发了人工智能驱动的早期预警评分软件eCART。
{"title":"Researchers Compared Hospital Early Warning Scores for Clinical Deterioration—Here’s What They Learned","authors":"Roy Perlis, Jennifer Abbasi","doi":"10.1001/jama.2024.24062","DOIUrl":"https://doi.org/10.1001/jama.2024.24062","url":null,"abstract":"This Medical News article is an interview with Dana P. Edelson, MD, MS, an expert in cardiac resuscitation at the University of Chicago and cofounder and chief medical officer of AgileMD, the company that makes the AI-driven early warning score software eCART.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142917620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kadija Ferryman, Deidra C. Crews, Emmanuel F. Drabo, Theodore J. Iwashyna, Odia Kane, John W. Jackson
This study examines temporal trends in US Food and Drug Administration clearance summaries for pulse oximeters that report information about race and ethnicity and/or skin color or tone.
{"title":"Adherence to FDA Guidance on Pulse Oximetry Testing Among Diverse Individuals, 1996-2024","authors":"Kadija Ferryman, Deidra C. Crews, Emmanuel F. Drabo, Theodore J. Iwashyna, Odia Kane, John W. Jackson","doi":"10.1001/jama.2024.26473","DOIUrl":"https://doi.org/10.1001/jama.2024.26473","url":null,"abstract":"This study examines temporal trends in US Food and Drug Administration clearance summaries for pulse oximeters that report information about race and ethnicity and/or skin color or tone.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142902148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Expert Consensus Offers Guidance for Treating Hair Loss With Low-Dose Oral Minoxidil.","authors":"Samantha Anderer","doi":"10.1001/jama.2024.25516","DOIUrl":"https://doi.org/10.1001/jama.2024.25516","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"148 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142887559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"CDC Calls Attention to Underuse of Antiviral Treatment in Higher-Risk Youth With Influenza.","authors":"Samantha Anderer","doi":"10.1001/jama.2024.25515","DOIUrl":"https://doi.org/10.1001/jama.2024.25515","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"87 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142887561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Global Measles Cases Rose 20% in 1 Year as Vaccine Coverage Fell Short.","authors":"Samantha Anderer","doi":"10.1001/jama.2024.25514","DOIUrl":"https://doi.org/10.1001/jama.2024.25514","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"699 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142887562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：